Ad
related to: modernathecountyoffice.com has been visited by 1M+ users in the past month
Search results
Moderna and MSD share encouraging three-year data from trial of melanoma therapy
Clinical Trials Arena via Yahoo Finance· 5 days agoPharmaceutical companies Moderna and Merck & Co (MSD) have announced positive results from the Phase...
First Human Death From Bird Flu Puts Vaccine Stocks On The Map -Moderna (NASDAQ:MRNA), CureVac...
Benzinga· 2 days agoVaccine stocks have been on the fly ever since a never-before-seen bird flu strain started infecting...
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 5 days agoOn Monday, RBC (TSX:RY) Capital Markets adjusted its outlook on Moderna (NASDAQ:MRNA) shares,...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 23 hours agoThe shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 6 days agoModerna has secured approval from the US Food and Drug Administration (FDA) for its mRNA-based respiratory syncytial virus (RSV) vaccine mRESVIA...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 2 days agoModerna’s respiratory syncytial virus (RSV) vaccine mRESVIA has received US Food and Drug...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 5 days agoInsights from TIME, The Washington Post, MIT Technology Review The News Pharmaceutical giants ...
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 22 hours agoTwo other companies – Pfizer and Moderna – also manufacture RSV vaccines approved for adults 60 and...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 5 days agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study in patients with ...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 6 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.